Patient-Reported Outcomes as Interradiographic Predictors of Response in Non–Small Cell Lung Cancer

PURPOSE: Minimally invasive biomarkers have been used as important indicators of treatment response and progression in cancers such as prostate and ovarian. Unfortunately, all biomarkers are not prognostic in all cancer types and are often not routinely collected. Patient-reported outcomes (PRO) pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhatt, Ambika S., Schabath, Matthew B., Hoogland, Aasha I., Jim, Heather S.L., Brady-Nicholls, Renee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2023
Materias:
Translational Cancer Mechanisms and Therapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10425729/
https://www.ncbi.nlm.nih.gov/pubmed/37233986
http://dx.doi.org/10.1158/1078-0432.CCR-23-0396

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10425729/
https://www.ncbi.nlm.nih.gov/pubmed/37233986
http://dx.doi.org/10.1158/1078-0432.CCR-23-0396

Ejemplares similares